Cannabidiol-induced intracellular Ca2+ elevations in hippocampal cells

Area of Science:

• Neuroscience
• Cell Biology
• Pharmacology

Background:

• Cannabidiol (CBD) is a non-psychotropic phytocannabinoid with therapeutic potential.
• The precise cellular mechanisms underlying CBD's effects are not fully understood.
• Understanding CBD's impact on calcium (Ca2+) homeostasis is crucial for its therapeutic applications.

Purpose of the Study:

• To investigate the effect of CBD on intracellular calcium ([Ca2+]i) homeostasis in hippocampal cells.
• To elucidate the specific cellular pathways involved in CBD-mediated calcium modulation.

Main Methods:

• Characterization of CBD's effect on [Ca2+]i in cultured hippocampal glia and neurons.
• Utilized various solutions to modulate cell excitability and extracellular calcium levels.
• Employed calcium channel blockers (cadmium, nifedipine) and intracellular store depletion (thapsigargin).
• Investigated the role of cannabinoid (CB1) and vanilloid (TRPV1) receptors using specific antagonists (AM281, capsazepine).

Main Results:

• CBD (1 microM) significantly increased [Ca2+]i in both glia and neurons.
• CBD-induced calcium responses were dependent on extracellular calcium availability and cell excitability.
• Cadmium and nifedipine partially reduced CBD's effect, indicating L-type voltage-gated calcium channel involvement.
• Thapsigargin-induced depletion of intracellular calcium stores fully blocked CBD's effect.
• CB1 and TRPV1 receptor antagonists enhanced CBD-induced calcium responses, suggesting negative coupling.

Conclusions:

• CBD modulates hippocampal calcium homeostasis primarily through intracellular calcium stores and L-type voltage-gated calcium channels.
• Cannabinoid and vanilloid receptor signaling negatively regulate CBD's impact on calcium homeostasis.
• These findings provide insights into the cellular mechanisms of CBD action.